What is aTyr Pharma's net income?

aTyr Pharma (ATYR) reported net income of -$10.79M in Q1 2026.

How has aTyr Pharma's net income changed year-over-year?

aTyr Pharma's net income increased by 27.5% year-over-year, from -$14.88M to -$10.79M.

What is the long-term trend for aTyr Pharma's net income?

Over 4 years (2021 to 2025), aTyr Pharma's net income has grown at a 21.7% compound annual growth rate (CAGR), from -$33.77M to -$74.12M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

aTyr Pharma ATYR Net Income

Net Income at other companies

Bristol-Myers SquibbBMY

$2.68B+9.0%

Merck & Co.MRK

-$4.24B-183%

United TherapeuticsUTHR

$274.9M-14.7%

Design Therapeutics, Inc.DSGN

-$17.64M+0.4%

Oric Pharmaceuticals, Inc.ORIC

-$35.77M-19.1%

Vor BiopharmaVOR

-$219.59M-576%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's net income?: aTyr Pharma (ATYR) reported net income of -$10.79M in Q1 2026.
How has aTyr Pharma's net income changed year-over-year?: aTyr Pharma's net income increased by 27.5% year-over-year, from -$14.88M to -$10.79M.
What is the long-term trend for aTyr Pharma's net income?: Over 4 years (2021 to 2025), aTyr Pharma's net income has grown at a 21.7% compound annual growth rate (CAGR), from -$33.77M to -$74.12M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.